domingo, 1 de marzo de 2020

The FDA in the 2020s: move forward, don't stand still - STAT

The FDA in the 2020s: move forward, don't stand still - STAT

First Opinion

The FDA in the 2020s: move forward, don’t stand still

By MARK MCCLELLAN AND ELLEN V. SIGAL


ANDREW HARNIK/AP
No agency faces more pressure to evolve with the industries it regulates than the FDA. It must build on what has worked to improve public health outcomes.

No hay comentarios: